2. Moderators:
Professors:
• Prof. Dr. G. Sivasankar, M.S., M.Ch.,
• Prof. Dr. A. Senthilvel, M.S., M.Ch.,
Asst Professors:
• Dr. J. Sivabalan, M.S., M.Ch.,
• Dr. R. Bhargavi, M.S., M.Ch.,
• Dr. S. Raju, M.S., M.Ch.,
• Dr. K. Muthurathinam, M.S., M.Ch.,
• Dr. D. Tamilselvan, M.S., M.Ch.,
• Dr. K. Senthilkumar, M.S., M.Ch.
Dept of Urology, GRH and KMC, Chennai. 2
3. Definition
• Growth factor is a naturally occurring substance
capable of stimulating cellular growth
proliferation and cellular differentiation
• Growth factors typically act as signaling
molecules between cells.
• Examples are cytokines and hormones that bind
to specific receptors on the surface of their target
cells.
• ? Cytokines
• G0 → G1 phase
3
Dept of Urology, GRH and KMC, Chennai.
6. Defn
• Growth factors are small peptide molecules that
stimulate, (or in some cases inhibit), cell division
and differentiation processes
• Cell surface receptors specific for that growth
factor that are linked to a variety of
transmembrane and intracellular signaling
mechanisms.
• Interactions between growth factors and steroid
hormones may alter the balance of cell
proliferation versus cell death
6
Dept of Urology, GRH and KMC, Chennai.
7. Patterns of cell growth
• Reversible
• Irreversible
7
Dept of Urology, GRH and KMC, Chennai.
8. 8
ONCOGENES
• Oncogenes are mutated forms of cellular
proto-oncogenes.
• Proto-oncogenes code for cellular proteins
which regulate normal cell growth and
differentiation.
Dept of Urology, GRH and KMC, Chennai.
9. 9
Class I: Growth Factors
Class II: Receptors for Growth Factors and Hormones
Class III: Intracellular Signal Transducers
Class IV: Nuclear Transcription Factors
Class V: Cell-Cycle Control Proteins
Five types of proteins encoded by proto-oncogenes participate in
control of cell growth:
Dept of Urology, GRH and KMC, Chennai.
10. 10
4. Nuclear
Proteins:
Transcription
Factors
5. Cell Growth
Genes
3. Cytoplasmic
Signal Transduction
Proteins
1. Secreted Growth Factors
2. Growth Factor Receptors
Functions of Cellular Proto-Oncogenes
Dept of Urology, GRH and KMC, Chennai.
16. FGF Family
• In humans, 22 members of the FGF family have been identified
• structurally related signaling molecules
• Members FGF1 through FGF10 all bind fibroblast growth factor receptors
• FGF1 is also known as acidic, and FGF2 is also known as basic fibroblast
growth factor.
• Members FGF11, FGF12, FGF13, and FGF14, also known as FGF
homologous factors 1-4 (FHF1-FHF4), have been shown to have distinct
functional differences compared to the FGFs - "iFGF".
• Human FGF20 was identified based on its homology to Xenopus FGF-20
(XFGF-20).[6][7]
• FGF15 through FGF23 were described later and not all their functions have
been characterized.
• FGF15/19, FGF21 and FGF23 have systemic effects.[8][9]
16
Dept of Urology, GRH and KMC, Chennai.
17. • Mitogens- pleuripotent / promiscuous gf
• mesoderm induction,
• antero-posterior patterning,
• limb development
• neural induction and neural development and in
• mature tissues/systems angiogenesis,
• keratinocyte organization, and
• wound healing processes.
• Endothelial cell proliferation - > VEGF/ PDGF
• NEUROGENESIS
17
Dept of Urology, GRH and KMC, Chennai.
18. IGFs
• Proteins Similar to Insulin
• Used by cells to communicate with their
physiological environment
• IGF
• IGFR (2)
• IGFL (2)
• IGFP (6)
• Proteases
18
Dept of Urology, GRH and KMC, Chennai.
19. IGF – GH AXIS
• GH stimulates IGF
• secreted by Liver
• IGF 1 – maximal growth / neural
• IGF2 – early growth factor (fetal)
19
Dept of Urology, GRH and KMC, Chennai.
20. Fn
• It acts as a neurotrophic factor, inducing the
survival of neurons.
• It causes skeletal muscle hypertrophy, by inducing
protein synthesis, and by blocking muscle
atrophy.
• It is protective for cartilage cells, and is associated
with activation of osteocytes, and thus may be an
anabolic factor for bone.
• Since at high concentrations it is capable of
activating the insulin receptor, it can also
complement for the effects of insulin.
20
Dept of Urology, GRH and KMC, Chennai.
22. • Antiproliferative factors in normal epithelial
cells
• SMADD / DAXX → APOPTOSIS
• Synthesis of p15 & p21 → cell cycle arrest at
G1
• Role in peyronie’s disease
22
Dept of Urology, GRH and KMC, Chennai.
23. EGF
Human EGF is a 6045-Da protein[2] with 53
amino acid residues and three
intramolecular disulfide bonds
The discovery of EGF won Stanley Cohen
and Rita Levi-Montalcini a Nobel Prize in
Physiology and Medicine in 1986
First purified from the mouse submandibular
gland, but since then found in many human
tissues including submandibular gland, parotid
gland.
Salivary EGF, which seems also regulated by
dietary inorganic iodine, also plays an
important mucosal healer
23
Dept of Urology, GRH and KMC, Chennai.
24. • Epidermal growth factor
can be found in human
platelets, macrophages,
urine, saliva, milk, and
plasma
24
Dept of Urology, GRH and KMC, Chennai.
26. Breast 14 % - 91 %
Colon 25 % - 77 %
Lung Cancer 40 % - 80 %
(Non small cell)
Ovarian 35 % - 70 %
Pancreatic 30 % - 50 %
Head & Neck 80 % - 95 %
EGFR Expression
Rate
Tumour
26
Dept of Urology, GRH and KMC, Chennai.
27. TK
TK
EGFR signal transduction in tumour cells
Survival
(anti-apoptosis)
PI3-K
STAT3
AKT
PTEN
MEK
Gene transcription
MAPK
Proliferation/
maturation
Chemotherapy /
radiotherapy
resistance
Angiogenesis
Metastasis
pY
pY
RAS RAF
SOS
GRB2
pY
G1
S
M
G2
27
Dept of Urology, GRH and KMC, Chennai.
28. EGFR - Variant III EGFR – Wild Type
No extracellular domain Present
Ligand cannot bind Can bind
TK constitutively active TK activated by ligand binding
Cannot dimerise Can dimerise
Not found in normal cells Found normally
More propensity for cancer Up regulation leads to cancer
How EGFR variant differs from the wild type
28
Dept of Urology, GRH and KMC, Chennai.
29. TK
Gene transcription
Cell Cycle Progression
Cell Proliferation Metastasis
Anti Apoptosis
Cancer
ATP
29
Dept of Urology, GRH and KMC, Chennai.
30. TK TK TK TK
Strategies to inhibit EGFR signaling
-
- - -
EGFR tyrosine
kinase inhibitors
Anti-EGFR mAbs
Anti-ligand
mAbs
Bispecific
Abs
Immune
effector
cell
ATP
30
Dept of Urology, GRH and KMC, Chennai.
31. Drugs Available
Gefitinib
Erlotinib
Highly selective, potent & reversible
EGFR Tyrosine Kinase Inhibitor
Cetuximab – Monoclonal Anti EGFR antibody
H 447
MDX 210
Bispecific Anti EGFR antibody
linked to Anti CD 64
31
Dept of Urology, GRH and KMC, Chennai.
32. TNFa
• principal mediator of acute
inflammation
• major source: macrophages
• LPS is a potent stimulator (through
TLR)
• major effect: activation of pro-
inflamm NFkB transcription factor
INFLAMMATORY
GENES
LPS-Toll-Like Receptors
TRAF
32
Dept of Urology, GRH and KMC, Chennai.
33. •Major actions:
• increase endothelial expression of selectins and integrins
• increase chemokine production in endothelial cells, macrophages
• increases cycloxygenase and lipoxygenase
• Increased arichodinate metabolism
• Production of prostaglandins and leukotrienes (pyrogens,
chemotactic)
• induces prostacyclin expression in endothelium – increases local
blood flow
• increase IL-1 production in macrophages
• induces apoptosis in some cells (through p55 receptor – activates
caspase)
• at high concentrations in blood, can induce septic shock, organ
failure, thrombosis, high mortality 33
Dept of Urology, GRH and KMC, Chennai.
35. • Lawson’s group was the first to demonstrate
that extracts of BPH stimulate cellular growth
35
Dept of Urology, GRH and KMC, Chennai.
36. BPH
• TGF Beta – role reversal
• Usually an epithelial cell proliferation inhibitor
• This is lost in BPH
• Induces proliiferation of stromal cells
• So TGF β1 = STROMAL COMPONENT
36
Dept of Urology, GRH and KMC, Chennai.
37. • FGF 2 → AUTOCRINE → epiithelial
proliferation
• FGF-7 (or a homolog) is the leading candidate
for the factor mediating the stromal cell–
based hormonal regulation of the prostatic
epithelium.
• FGF 17,10
• VEGF
• IGF 1
37
Dept of Urology, GRH and KMC, Chennai.